LAA Frankfurt 2017 - Home


November 17 – 18, 2017
Frankfurt, Germany

LAA Frankfurt 2017: Left Atrial Appendage - LAA 2017 LAA 2017 Left Atrial Appendage
LAA Frankfurt 2017

LAA 2017
How to close the
Left Atrial Appendage



Please subscribe to our
csi pfeil
newsletter

Add to my calendar

LAA 2017 Abstract & Case Submission Topics Registration Faculty Scientific Program Impressions Archive Key Information Event Calendar Sponsors
Fontsize bigger
  LAA Frankfurt 2017: Left Atrial Appendage
LAA Frankfurt 2017: Left Atrial Appendage

Board of Directors

Maurice Buchbinder, MD

Foundation for Cardiovascular Medicine
San Diego
USA

Board of Directors: Maurice Buchbinder, MD

Shakeel A. Qureshi, MD

Evelina Children's Hospital
London
United Kingdom

Board of Directors: Shakeel A. Qureshi, MD
More

Shakeel A. Qureshi, MD

Evelina Children's Hospital
London, United Kingdom

Board of Directors: Shakeel A. Qureshi, MD
Consultant Paediatric Cardiologist / Head of Service

Area of expertise

interventional paediatric and adult congenital heart disease

Languages spoken

English, Urdu, Punjabi

Biography

Professor Shakeel Qureshi trained in paediatric cardiology at Harefield, Guy's and Liverpool Hospitals. He was first appointed consultant at Liverpool in 1987 and consultant paediatric cardiologist/senior lecturer at Guy's and St Thomas' in 1988.
Professor Qureshi is involved with earthquake relief work in Kashmir, charity fundraising for building houses in Kashmir and Indonesia and other medical charity missions. He is also on the Chain of Hope medical board.

Specialist Interests

  • interventional paediatric cardiology (keyhole surgery techniques)
  • co-inventor of Tyshak balloon.

Research Interests

  • developing or evaluating devices for treating congenital heart defects
  • involved in evaluating a new percutaneous pulmonary valve.

Awards

  • Sitara-e-Imtiaz (one of the highest civil awards) by the Pakistan Government for services to medicine in 2004
  • PICS Outstanding Achievement award (judged by the profession) in Chicago in 2004.

Publications

Professor Qureshi has published over 170 papers and several reviews and book chapters, co-editing a text book of interventional paediatric cardiology.

Vivek Reddy, MD

The Mount Sinai Medical Center
New York City
USA

Board of Directors: Vivek Reddy, MD

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Apostolos Tzikas, MD

AHEPA University Hospital / Interbalkan European Medical Center
Thessaloniki
Greece

Board of Directors: Apostolos Tzikas, MD
More

Apostolos Tzikas, MD

AHEPA University Hospital / Interbalkan European Medical Center
Thessaloniki, Greece

Board of Directors: Apostolos Tzikas, MD
www.apostolostzikas.gr

Neil Wilson, MD

School of Medicine, University of Colorado, Childrens Hospital Colorado
Denver
USA

Board of Directors: Neil Wilson, MD

Co-Directors

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis
USA

Co-Directors: Stefan Bertog, MD
More

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis, USA

Co-Directors: Stefan Bertog, MD
Specialist in Cardiology, Angiology and Interventional Cardiology at CVC Frankfurt since February 2013

  • Since 2006 Assistant Professor, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
  • 2010 - Present Co-Director of Cardiac Catheterization Laboratory, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2006 - Present Cardiologist, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2003 - 2005 Chief Fellow Cardiology,, University of Minnesota, Minneapolis, Minnesota, USA
  • 2002 - 2006 Fellowship, Cardiology and Interventional Cardiology at University of Minnesota, Minneapolis, USA
  • 1999 - 2002 Residency, Internal Medicine at the Cleveland Clinic Hospital, Cleveland, Ohio, USA
  • 1997 - 1998 Junior Physician, Department of Cardiology at Municipal Hospital in Frankfurt Höchst, Germany
  • 1990 - 1997 Medical Degree at Johann Gutenberg University in Mainz, Germany







Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle
USA

Co-Directors: Sameer  Gafoor, MD
More

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle, USA

Co-Directors: Sameer  Gafoor, MD
Attending Physician

Dr. Sameer Gafoor is an attending physician at the CardioVascular Center (CVC) Frankfurt headed by Horst Sievert, MD. He obtained his medical degree from Northwestern University in the United States, followed by Internal Medicine Residency at University of michigan. His cardiology training started with Cardiovascular Disease Fellowship at Washington Hospital Center/Georgetown University and continued with Interventional Cardiology Fellowship at Emory University.

Following this training, he went on to complete an Advanced Fellowship in Neurovascular, Coronary, Structural Heart, and Peripheral Vascular Training at the CVC Frankfurt. He specializes in interventions and imaging for structural heart and peripheral vascular disease, as well as development and incorporation of new devices, technologies, and techniques for these and other indications.

Faculty

Mohamad Alkhouli, MD

West Virginia University
Morgantown
USA

Faculty: Mohamad Alkhouli, MD
More

Mohamad Alkhouli, MD

West Virginia University
Morgantown, USA

Faculty: Mohamad Alkhouli, MD
Mohamad Alkhouli, MD. FACC. is an academic interventional cardiologist with special focus on transcatheter treatment of structural heart conditions. Dr. Alkhouli completed training in internal medicine, cardiology and vascular medicine at Temple University in Philadelphia where he also served as a chief medical resident. He completed additional training in coronary and endovascular interventions at the University of Rochester before moving to Mayo Clinic to pursue advanced training in structural heart disease interventions.  Dr. Alkhouli is currently an assistant professor of medicine and an associate director of the cardiovascular fellowship at West Virginia University. He is also the co-director of the Center of Mitral Valve Diseases at the WVU Heart and Vascular Institute.

Adel Aminian, MD

Centre hospitalier universitaire de Charleroi
Charleroi
Belgium

Faculty: Adel Aminian, MD
More

Adel Aminian, MD

Centre hospitalier universitaire de Charleroi
Charleroi, Belgium

Faculty: Adel Aminian, MD
Dr Aminian and his team in CHU Charleroi have started a LAA closure program in 2011. Since then, around 105 LAA closure procedures have been performed successfully by using both the Amplatzer device or the Watchman occluder.
CHU Charleroi is currently amongst the most experienced center in Belgium. Dr Aminian is also an active proctor for Sant Jude Medical and Boston Scientific. As such, Dr Aminian has participated in more than 400 implantations and helped to launch the technique in several countries all around the world.

Raveen Bazaz, MD

University of Pittsburgh Medical Center

United States of America

Faculty: Raveen Bazaz, MD

Martin W. Bergmann, MD

Cardiologicum Hamburg
Hamburg
Germany

Faculty: Martin W. Bergmann, MD
More

Martin W. Bergmann, MD

Cardiologicum Hamburg
Hamburg, Germany

Faculty: Martin W. Bergmann, MD
Professional Experience

  • Since July 2014 Interventional Cardiologist
  • 05/2008 - 06/2014 Assistant Director and executive deputy Cardiology

Sergio Berti, MD

Fondazione Toscana G. Monasterio CNR
Massa
Italy

Faculty: Sergio Berti, MD
More

Sergio Berti, MD

Fondazione Toscana G. Monasterio CNR
Massa, Italy

Faculty: Sergio Berti, MD
Dr. Sergio Berti is head of the Diagnostic and Interventional Cardiology Department of the Fondazione Toscana G. Monasterio – Ospedale del Cuore in Massa, as well as Head of the Interventional Cardiology Department in the Pisa branch of the Fondazione Toscana G. Monasterio. He leads clinical care activities as well as research in the field of cardiovascular pathologies in adults. His main areas of interest are the treatment of structural cardiological diseases, transcatheter valve implants, transcatheter Left Atrial Appendage Occlusion and the treatment of aorta aneuryms via endoprostheses. He has participated in  numerous international clinical trials as principal investigator, as well as being coordinator for a number of national and international projects. Dr. Berti has carried out didactic activities for many courses and is tutor for degree theses and research doctorates. In 2014 he was elected President of the Italian Society for Invasive Cardiology GISE.

Ronald Binder, MD

University of Zurich
Zurich
Switzerland

Faculty: Ronald Binder, MD
More

Ronald Binder, MD

University of Zurich
Zurich, Switzerland

Faculty: Ronald Binder, MD
Ronald K. Binder MD is interventional cardiologist at the University of Zurich, Switzerland. His speciality is structural heart disease interventions including TAVI and LAA closure, which he is both proctoring. Previously he worked at the University of British Columbia, Vancouver, Canada, with Professor John G Webb and at the University of Bern, Switzerland, with Professor Bernhard Meier and Professor Stephan Windecker. After graduating from medical school at the University of Vienna, Austria, he performed research at the University of Tübingen, Germany.
Dr. Binder has published extensive work on TAVI including several first in man trials as well as studies on ICE for LAA closure and other percutaneous heart disease interventions.

Lucas Boersma, MD

St Antonius Hospital
Nieuwegein
The Netherlands

Faculty: Lucas Boersma, MD
More

Lucas Boersma, MD

St Antonius Hospital
Nieuwegein, The Netherlands

Faculty: Lucas Boersma, MD

Dr. Lucas Boersma is a cardiologist/electrphysiologist at St.Antonius Hospital in Nieuwegein. He has been performing LAAC since 2009. He is the PI of the EWOLUTION trial, and is part of the ASAP-TOO and AMULET IDE trial.. His main focus lies on combining AF ablation and LAAC in a single procedure.


Mario Carminati, MD

I.R.C.C.S. Policlinico San Donato
Milan
Italy

Faculty: Mario Carminati, MD

Ignacio Cruz-Gonzalez, MD

University Hospital of Salamanca
Salamanca
Spain

Faculty: Ignacio Cruz-Gonzalez, MD

Matthew Daniels, MD

John Radcliffe Hospital
Oxford
United Kingdom

Faculty: Matthew Daniels, MD
More

Matthew Daniels, MD

John Radcliffe Hospital
Oxford, United Kingdom

Faculty: Matthew Daniels, MD
Matthew is an Honorary Consultant Cardiologist at the John Radcliffe Hosptial with clinical practice in adult structural intervention and inherited cardiac conditions. He joined the LAAO implanting team in 2010 when Oxford was the UK lead site for the multi-centre intial Amplatzer Cardiac Plug registry. Funding arrangements set out by the National Health Service in the UK enables only AF patients at high stroke risk with a contra-indication to oral anticoagulation to be treated by LAAO. He has no conflicts of interest to declare.

Ole De Backer, MD

The Heart Center - Rigshospitalet
Copenhagen
Denmark

Faculty: Ole De Backer, MD

Marvin Eng, MD

Henry Ford Health System
Detroit
USA

Faculty: Marvin Eng, MD
More

Marvin Eng, MD

Henry Ford Health System
Detroit, USA

Faculty: Marvin Eng, MD
Marvin H. Eng MD graduate from Wayne State School of Medicine and completed his internal medicine and general cardiology training at the University of Colorado Health Sciences Center. Subsequently, Dr. Eng completed his interventional cardiology training at the Scripps Clinic in La Jolla, California.  His first faculty appointment was at the University of Texas Health Sciences Center-San Antonio where he started the TAVR program at the University.  Since arriving back in Detroit in 2015, Dr. Eng currently serves as the Structural Heart Disease (SHD) Fellowship and the SHD research director.  His focus includes imaging, large bore access, TAVR and mitral interventions.   

Xavier Freixa, MD

Hospital Clinic of Barcelona
BARcelona
Spain

Faculty: Xavier Freixa, MD

Alexander Ghanem

Asklepios Klinik St. Georg
Hamburg
Germany

Faculty: Alexander Ghanem
More

Alexander Ghanem

Asklepios Klinik St. Georg
Hamburg, Germany

Faculty: Alexander Ghanem
Professor Ghanem obtained his MD and PhD in 2003 and received since then his interventional training at the University Heart Center Bonn, Germany (Prof. Nickenig; Prof. Grube). In 2014 he was appointed as managing consultant and associate director of cardiology at the Asklepios Klinik St. Georg in Hamburg (Prof. Kuck). Alexander Ghanem further serves as an Associate Professor of Medicine and Cardiology at the University of Bonn. His clinical interestst comprise interventional treatment of complex coronary artery disease and aortic stenosis. His research interests focus on neurological complications of transcatheter aortic valve implantation.

Eberhard Grube, MD

University Hospital Bonn
Bonn
Germany

Faculty: Eberhard Grube, MD
More

Eberhard Grube, MD

University Hospital Bonn
Bonn, Germany

Faculty: Eberhard Grube, MD
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC)University Hospital Bonn,Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

His research interest include drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.

David Hildick-Smith, MD

Brighton and Sussex University Hospital
Brighton
United Kingdom

Faculty: David Hildick-Smith, MD

Reda Ibrahim, MD

University of Montreal, Institut of Cardiology
Montreal
Canada

Faculty: Reda Ibrahim, MD
More

Reda Ibrahim, MD

University of Montreal, Institut of Cardiology
Montreal, Canada

Faculty: Reda Ibrahim, MD
Dr Reda Ibrahim is a cardiologist at the Montreal Heart Institute and an Associate Professor at the University of Montreal. He studied Internal Medicine and Cardiology at the University of Montreal. In 2001-2002, he conducted a subspecialty in adult congenital and structural interventions at the Brigham and Women and Children's Hospitals of Harvard University in Boston. Dr. Ibrahim is the Medical Director of the Structural Heart Diseases Program since 2014 and is the former Director of the Medical Intensive Care Unit (2006-2014). He has won several awards and honors including the professor of the year from the Department of Medicine in 2004 and 2005. In term of research, he was the principal investigator of several important studies (CLOSURE-1, PC-trial, RESPECT, PRIMA, REDUCE, etc.). As other achievements, he has many publications, numerous presentations in major congresses (TCT, EuroPCR, PICS, CSI, AHA, ACC-i2 Summit, ESC), a number of Canadian and North American premieres, live proceedings at various conferences (ACC-TCT-EuroPCR-PICS-ISLAA), and "proctor" activities for different companies.

Dhjanunjaya Lakkireddy, MD

The University of Kansas Hospital

USA

Faculty: Dhjanunjaya Lakkireddy, MD

Randy Lee, MD

University of California
San Francisco
USA

Faculty: Randy Lee, MD
More

Randy Lee, MD

University of California
San Francisco, USA

Faculty: Randy Lee, MD
Education
1984 UCLA School of Medicine 

Residencies
1988 Harbor-UCLA Medical Center, Internal Medicine
 
Fellowships
1991 Stanford University Medical Center, Cardiovascular Diseases 

Dr. Randall J. Lee graduated from UCLA Medical School in 1984 where he also obtained his doctorate in pharmacology. After completing an internal medicine residency at Harbor-UCLA Medical Center in Torrance, Calif., he completed a cardiology fellowship and postdoctoral fellowship in biochemistry and molecular biology at Stanford University, where he earned a Physician Scientist Award and the Upjohn Young Investigator Award in cardiology. Lee subspecialized in cardiac electrophysiology during his second fellowship at UCSF.
His research focuses on cellular and molecular aspects of cardiac arrhythmias and vascular regeneration. He is investigating the cellular and molecular derangements that occur during cardiac arrhythmias and myocardial infarctions. Lee uses genetic engineering techniques to investigate derangements during cardiac arrhythmias and myocardial infarctions and as possible therapeutic tools. Lee also is interested in cardiac development of the conduction system and the means to alter conduction, which then may be applied to diseased states.

Iqbal Malik, MD

Hammersmith Hospital
London
United Kingdom

Faculty: Iqbal Malik, MD

Karen McCarthy

Royal Brompton Hospital
London
United Kingdom

Faculty: Karen McCarthy

Trevor McCaw

Aegis Medical
Vancouver
Canada

Faculty: Trevor McCaw

Suneet Mittal, MD

Valley Hospital
New York
USA

Faculty: Suneet Mittal, MD
More

Suneet Mittal, MD

Valley Hospital
New York, USA

Faculty: Suneet Mittal, MD
Dr. Mittal earned his BA and MD degrees from Boston University. He did his Internal Medicine residency and Cardiology fellowship at the Hospital of the University of Pennsylvania. He then completed a fellowship in Electrophysiology at Weill Cornell Medical Center. He is currently the Director of the Electrophysiology Laboratory at The Valley Hospital in New Jersey. Dr. Mittal’s active research interests include the role of implantable monitors in patients with known or suspected arrhythmias and overcoming barriers to remote patient monitoring. He serves as the Heart Rhythm Society’s Co-Ambassador to India. He is currently an Editorial Board member of Circulation Arrhythmia and Electrophysiology, Heart Rhythm and the Journal of Interventional Cardiovascular Electrophysiology.

Jens Erik Nielsen-Kudsk, MD

Aarhus University Hospital
Aarhus N
Denmark

Faculty: Jens Erik Nielsen-Kudsk, MD
More

Jens Erik Nielsen-Kudsk, MD

Aarhus University Hospital
Aarhus N, Denmark

Faculty: Jens Erik Nielsen-Kudsk, MD
Ass. Professor, MD, DMSc

Congenital and Structural Heart Interventionalist at Department of Cardiology,
Aarhus University Hospital, Skejby, Aarhus, Denmark

Fabian Nietlispach, MD

University Heart Center, Cardiovascular Centre
Zurich
Switzerland

Faculty: Fabian Nietlispach, MD
More

Fabian Nietlispach, MD

University Heart Center, Cardiovascular Centre
Zurich, Switzerland

Faculty: Fabian Nietlispach, MD
Experience

2013 – today
Head TAVI, Interventional Cardiologist, Cardiovascular Centre University Hospital Zurich, Switzerland
  • Head transfemoral TAVI program
  • TAVI, LAA occlusion, paravalvular leak closure, PFO/ASD-closure, structural interventions
  • TAVI Proctor for Edwards Lifesciences
  • Proctor for Amplatzer Left atrial appendage occlusion
2011 – 2013
Attending Physician Invasive Cardiology Inselspital Bern, Switzerland

2008 – 2010
Fellow Interventional Cardiology, St. Paul's Hospital The University of British Columbia, Vancouver, Canada

Bushra Rana, MD

Papworth Hospital
Cambridge
United Kingdom

Faculty: Bushra  Rana, MD

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver
Canada

Faculty: Jacqueline Saw, MD
More

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver, Canada

Faculty: Jacqueline Saw, MD
Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital and St Paul’s Hospital, Clinical Associate Professor of Medicine at UBC, and Program Director of the VGH Interventional Cardiology Fellowship Program. She served as Head of VGH Cardiology Clinical Trials Research. She is an active physician proctor for LAA closure with WATCHMAN and ACP/Amulet devices.

Dr. Saw is a pioneer in research and management of spontaneous coronary artery dissection (SCAD) and is the PI of the CIHR-funded multi-center prospective Canadian SCAD Study. Other research interests include LAA closure, coronary fibromuscular dysplasia, antiplatelet therapy, carotid artery stenting, peripheral arterial disease and intervention. She is also PI of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has co-authored over 130 peer-reviewed publications, and is the editor of three textbooks on LAA closure and carotid artery stenting.

Kolja Sievert

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Faculty: Kolja Sievert

Lars Sondergaard, MD

Rigshospitalet
Copenhagen
Denmark

Faculty: Lars Sondergaard, MD

Vijay Swarup, MD

Arizona Heart Rhythm Center
Phoenix
United States of America

Faculty: Vijay Swarup, MD
More

Vijay Swarup, MD

Arizona Heart Rhythm Center
Phoenix, United States of America

Faculty: Vijay Swarup, MD
Dr. Swarup is a cardiac electrophysiologist who specializes in all aspects of atrial fibrillation care, including ablation and LAA closure procedures. He is one of the most experienced LAA closure device implanters in the United States. He began implanting LAA closure devices in 2006 and has participated as Principal Investigator for all original Watchman clinical trials. He has since implanted more than 300 Watchman devices and is one of the leading implanters of the Amulet device. Dr Swarup is a national proctor for Watchman, Lariat and Amulet closure devices. He is currently involved in Watchman, Amulet, Wavecrest and Lariat clinical trials.

Laura Vaskelyte, MD

CardioVascular Center Frankfurt
Frankfurt
Germany

Faculty: Laura Vaskelyte, MD
More

Laura Vaskelyte, MD

CardioVascular Center Frankfurt
Frankfurt, Germany

Faculty: Laura Vaskelyte, MD
Specialist in Internal Medicine and Cardiology.
At CVC Frankfurt since June 2012.
  • 1995 - 2001 Kaunas University of Health Sciences, Lithuania, Medical Degree with honors (magna cum laude)
  • 2002 - 2006 Specialization in cardiology at Kaunas University of Health Sciences, Lithuania
  • 2006 - 2007 Specialist in cardiology at St. Marien Hospital in Siegen, Germany
  • 2007 - 2009 Cardiologist at HELIOS-Clinic (Department of Internal Medicine, Cardiology, Angiology and Nephrology) in Aue, Germany
  • 2009 - 2011 Senior Cardiologist at HELIOS-Clinic (Department of Internal Medicine, Cardiology, Angiology, and Nephrology) in Aue, Germany
  • 2012 Senior Cardiologist at Municipal Hospital in Karlsruhe, Germany (Department of Internal Medicine, Cardiology, Angiology and Intensive Care)
  • Since 2012 Specialist in Cardiology, Interventional Cardiology Echocardiography, and Vascular Medicine at the CVC Frankfurt, St. Katharinen Hospital, Frankfurt am Main, Germany

Associated Faculty

Information will be available soon.


CSI   CSI
Contact Data Privacy Imprint Home CSI 2017